• About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Menu Menu
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram

Peel Therapeutics Reports Excessive NETosis Induction in Long COVID

April 13, 2023/in News/by Trent Fowler
Read more
/wp-content/uploads/peel_logo.svg 0 0 Trent Fowler /wp-content/uploads/peel_logo.svg Trent Fowler2023-04-13 08:30:582023-04-13 06:52:59Peel Therapeutics Reports Excessive NETosis Induction in Long COVID

Peel Therapeutics Closes New Financing Round and Expands Board of Directors to Support Evolution-Based Medicines for Cancer and Inflammation

February 23, 2023/in News/by Trent Fowler
Read more
/wp-content/uploads/peel_logo.svg 0 0 Trent Fowler /wp-content/uploads/peel_logo.svg Trent Fowler2023-02-23 07:00:162023-02-23 06:44:23Peel Therapeutics Closes New Financing Round and Expands Board of Directors to Support Evolution-Based Medicines for Cancer and Inflammation

PEEL Therapeutics Initiates Clinical Trial of PEEL-224 in Patients with Advanced Solid Tumors

August 10, 2022/in News/by Elizabeth Solorio
Read more
/wp-content/uploads/peel_logo.svg 0 0 Elizabeth Solorio /wp-content/uploads/peel_logo.svg Elizabeth Solorio2022-08-10 00:00:002022-08-10 05:05:30PEEL Therapeutics Initiates Clinical Trial of PEEL-224 in Patients with Advanced Solid Tumors

PEEL Therapeutics Developing Cancer Drug from Plant Toxin

August 24, 2020/in News/by David Anderson
Read more
/wp-content/uploads/peel_logo.svg 0 0 David Anderson /wp-content/uploads/peel_logo.svg David Anderson2020-08-24 08:00:002022-07-22 12:54:35PEEL Therapeutics Developing Cancer Drug from Plant Toxin

PEEL Therapeutics Announces Possible New Treatment for COVID-19

June 29, 2020/in News/by David Anderson
Read more
/wp-content/uploads/peel_logo.svg 0 0 David Anderson /wp-content/uploads/peel_logo.svg David Anderson2020-06-29 00:14:142022-07-22 12:56:32PEEL Therapeutics Announces Possible New Treatment for COVID-19
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram
  • Home
  • About
    • Who We Are
    • Approach
    • Mission and Vision
    • Our Leadership
  • Science
    • Our Platform
    • R&D Engine
    • Publications
  • Pipeline
    • Overview
    • PEEL-224
    • EP53
    • Melittin
    • NTPs
  • Careers
    • Our Culture
    • Open Positions
  • News
    • Press Releases
    • In the News
  • Contact
    • Get in Touch
    • Linked In
    • Twitter
    • Instagram

© 2023 Peel Therapeutics | All rights reserved |

Privacy Policy | Site Terms
Scroll to top